B Belgadi - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

B Belgadi

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Bulletin Du Cancer|January 1, 1990

[Hodgkin's disease in developing countries]B Belgadi, H Eghbali, B Hoerni

Annales D'Oto-Laryngologie Et De Chirurgie Cervico Faciale : Bulletin De La Societe D'Oto-Laryngologie Des Hopitaux De Paris|January 1, 1990

[Radiotherapy of carcinoma of the nasopharynx]B Belgadi, P Richaud, P Lagarde, et al.

ESMO Open|May 1, 2024

Prognostic value of EndoPredict test in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative primary breast cancer screened for the randomized, double-blind, phase III UNIRAD trialF Penault-Llorca, F Dalenc, S Chabaud, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Bulletin Du Cancer|January 1, 1990

[Hodgkin's disease in developing countries]B Belgadi, H Eghbali, B Hoerni

Annales D'Oto-Laryngologie Et De Chirurgie Cervico Faciale : Bulletin De La Societe D'Oto-Laryngologie Des Hopitaux De Paris|January 1, 1990

[Radiotherapy of carcinoma of the nasopharynx]B Belgadi, P Richaud, P Lagarde, et al.

ESMO Open|May 1, 2024

Prognostic value of EndoPredict test in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative primary breast cancer screened for the randomized, double-blind, phase III UNIRAD trialF Penault-Llorca, F Dalenc, S Chabaud, et al.

Pageof 1